Somatico Pharmacal Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 31-12-2024
- Paid Up Capital ₹ 1.60 M
as on 31-12-2024
- Company Age 47 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.50 Cr
as on 31-12-2024
- Satisfied Charges ₹ 3.35 Cr
as on 31-12-2024
- Revenue 34.55%
(FY 2023)
- Profit 555.59%
(FY 2023)
- Ebitda 303.73%
(FY 2023)
- Net Worth 13.70%
(FY 2023)
- Total Assets 22.04%
(FY 2023)
About Somatico Pharmacal
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.60 M.
The company currently has active open charges totaling ₹1.50 Cr. The company has closed loans amounting to ₹3.35 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Somatico Pharmacal Private Limited India is Avinash Shetty as CFO. Samita Aiyer and Dipali Rao serve as directors at the Company.
- CIN/LLPIN
U24230MH1977PTC019812
- Company No.
019812
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Aug 1977
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- LocationNavi Mumbai, Maharashtra
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Somatico Pharmacal Private Limited offer?
Somatico Pharmacal Private Limited offers a wide range of products and services, including Medical Surgery & Treatment Centres, Medical Treatment Services, Medical Consultants & Clinics, Dermatology Treatment Services, Pain Clinic Services, Respiratory Therapy Equipment, Health Care Service, Women Health Services, Skin Care, Bath Essentials.
Who are the key members and board of directors at Somatico Pharmacal?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Avinash Shetty | CFO | 01-Jun-2017 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Samita Aiyer  | Director | 01-Sep-1979 | Current |
| Dipali Rao | Director | 09-Jan-2019 | Current |
Financial Performance of Somatico Pharmacal.
Somatico Pharmacal Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 34.55% increase. The company also saw a substantial improvement in profitability, with a 555.59% increase in profit. The company's net worth Soared by an impressive increase of 13.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Somatico Pharmacal?
In 2023, Somatico Pharmacal had a public holding of 19.07%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Somazen Systems And Services Private LimitedActive 13 years 1 monthSamita Aiyer and Dipali Rao are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 02 Sep 2020 | ₹1.50 Cr | Open |
Hdfc Bank Limited Creation Date: 16 Feb 2019 | ₹3.00 M | Satisfied |
Others Creation Date: 20 Mar 2018 | ₹1.00 M | Satisfied |
How Many Employees Work at Somatico Pharmacal?
Somatico Pharmacal has a workforce of 176 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Somatico Pharmacal, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Somatico Pharmacal's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
